| pubmed-article:19352137 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19352137 | lifeskim:mentions | umls-concept:C0035608 | lld:lifeskim |
| pubmed-article:19352137 | lifeskim:mentions | umls-concept:C0596545 | lld:lifeskim |
| pubmed-article:19352137 | lifeskim:mentions | umls-concept:C0939237 | lld:lifeskim |
| pubmed-article:19352137 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
| pubmed-article:19352137 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
| pubmed-article:19352137 | lifeskim:mentions | umls-concept:C1524063 | lld:lifeskim |
| pubmed-article:19352137 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:19352137 | pubmed:dateCreated | 2009-4-13 | lld:pubmed |
| pubmed-article:19352137 | pubmed:abstractText | Thirty-four patients treated concomitantly with lopinavir/ritonavir and rifampicin were evaluated. Overall, only 15% used the recommended increased dose of lopinavir/ritonavir. Of patients on a nonadjusted dose of lopinavir/ritonavir, 67% had a subtherapeutic lopinavir plasma concentration and 38% had a detectable viral load. Forty percent of patients on an increased dose of lopinavir/ritonavir prematurely stopped the drug combination because of adverse events. Combined use of lopinavir/ritonavir and rifampicin is challenging as it implies balancing between suboptimal efficacy and toxicity. | lld:pubmed |
| pubmed-article:19352137 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19352137 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19352137 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19352137 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19352137 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19352137 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19352137 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19352137 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19352137 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19352137 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:19352137 | pubmed:issn | 1473-5571 | lld:pubmed |
| pubmed-article:19352137 | pubmed:author | pubmed-author:BurgerDavid... | lld:pubmed |
| pubmed-article:19352137 | pubmed:author | pubmed-author:AarnoutseRob... | lld:pubmed |
| pubmed-article:19352137 | pubmed:author | pubmed-author:van... | lld:pubmed |
| pubmed-article:19352137 | pubmed:author | pubmed-author:PrinsJan MJM | lld:pubmed |
| pubmed-article:19352137 | pubmed:author | pubmed-author:BrinkmanKeesK | lld:pubmed |
| pubmed-article:19352137 | pubmed:author | pubmed-author:BoereeMartinM | lld:pubmed |
| pubmed-article:19352137 | pubmed:author | pubmed-author:GrasLuukL | lld:pubmed |
| pubmed-article:19352137 | pubmed:author | pubmed-author:JuttmannJob... | lld:pubmed |
| pubmed-article:19352137 | pubmed:author | pubmed-author:NijlandHannek... | lld:pubmed |
| pubmed-article:19352137 | pubmed:author | pubmed-author:L'hommeRafaël... | lld:pubmed |
| pubmed-article:19352137 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19352137 | pubmed:day | 27 | lld:pubmed |
| pubmed-article:19352137 | pubmed:volume | 23 | lld:pubmed |
| pubmed-article:19352137 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19352137 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19352137 | pubmed:pagination | 863-5 | lld:pubmed |
| pubmed-article:19352137 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:19352137 | pubmed:meshHeading | pubmed-meshheading:19352137... | lld:pubmed |
| pubmed-article:19352137 | pubmed:meshHeading | pubmed-meshheading:19352137... | lld:pubmed |
| pubmed-article:19352137 | pubmed:meshHeading | pubmed-meshheading:19352137... | lld:pubmed |
| pubmed-article:19352137 | pubmed:meshHeading | pubmed-meshheading:19352137... | lld:pubmed |
| pubmed-article:19352137 | pubmed:meshHeading | pubmed-meshheading:19352137... | lld:pubmed |
| pubmed-article:19352137 | pubmed:meshHeading | pubmed-meshheading:19352137... | lld:pubmed |
| pubmed-article:19352137 | pubmed:meshHeading | pubmed-meshheading:19352137... | lld:pubmed |
| pubmed-article:19352137 | pubmed:meshHeading | pubmed-meshheading:19352137... | lld:pubmed |
| pubmed-article:19352137 | pubmed:meshHeading | pubmed-meshheading:19352137... | lld:pubmed |
| pubmed-article:19352137 | pubmed:meshHeading | pubmed-meshheading:19352137... | lld:pubmed |
| pubmed-article:19352137 | pubmed:meshHeading | pubmed-meshheading:19352137... | lld:pubmed |
| pubmed-article:19352137 | pubmed:meshHeading | pubmed-meshheading:19352137... | lld:pubmed |
| pubmed-article:19352137 | pubmed:meshHeading | pubmed-meshheading:19352137... | lld:pubmed |
| pubmed-article:19352137 | pubmed:meshHeading | pubmed-meshheading:19352137... | lld:pubmed |
| pubmed-article:19352137 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19352137 | pubmed:articleTitle | Clinical experience with the combined use of lopinavir/ritonavir and rifampicin. | lld:pubmed |
| pubmed-article:19352137 | pubmed:affiliation | Department of Clinical Pharmacy, Radboud University Nijmegen Medical Centre, 6525 GA Nijmegen, The Netherlands. | lld:pubmed |
| pubmed-article:19352137 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19352137 | lld:pubmed |
